BTAIVSISPC• 28 Days (Normalized)
BTAI vs ISPC (BioXcel Therapeutics Inc. vs iSpecimen Inc.)
Showing Closing Date Range from Aug, 17 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
ISPC Performance $1.47
-31.63%
iSpecimen Inc.
Normalized Baseline0.00%
Alpha Spread Margin BTAI LEADS
+31.63%
BTAI outperforming by 31.63%
BTAIISPC
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI ISPC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | BTAI Price | BTAI Gain (%) | ISPC Price | ISPC Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $- | $1.47 | -31.63% | - | |
| Sep 11, 2026 | $0.05 | -94.27% | $1.47 | -31.63% | -62.64% |
| Sep 10, 2026 | $0.05 | -94.38% | $1.50 | -30.23% | -64.15% |
| Sep 09, 2026 | $0.05 | -94.72% | $1.55 | -27.91% | -66.81% |
| Sep 08, 2026 | $0.04 | -95.17% | $1.59 | -26.05% | -69.12% |
| Sep 04, 2026 | $0.07 | -91.70% | $1.54 | -28.37% | -63.33% |
| Sep 03, 2026 | $0.12 | -86.74% | $1.54 | -28.37% | -58.37% |
| Sep 02, 2026 | $0.11 | -87.98% | $1.49 | -30.70% | -57.28% |
| Sep 01, 2026 | $0.14 | -84.61% | $1.50 | -30.23% | -54.38% |
| Aug 31, 2026 | $0.16 | -81.69% | $1.54 | -28.37% | -53.32% |
| Aug 28, 2026 | $0.18 | -79.66% | $1.54 | -28.37% | -51.29% |
| Aug 27, 2026 | $0.72 | -19.21% | $1.60 | -25.58% | +6.37% |
| Aug 26, 2026 | $0.78 | -12.36% | $1.64 | -23.72% | +11.36% |
| Aug 25, 2026 | $0.74 | -16.63% | $1.60 | -25.58% | +8.95% |
| Aug 24, 2026 | $0.76 | -14.49% | $1.57 | -26.98% | +12.49% |
Page 1 of 2